Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Cannlabs Inc. (CANL : OTCBB)

• Company Description    CannLabs, Inc. provides solutions for intellectual property, cloud-based analytics and scientific methods to serve the cannabis industry. It provides cannabis testing services for potency, homogeneity, microbial contamination, aflatoxins, heavy metals, residual solvents, and pesticides. The company also offers data/analytics and consulting, as well as education services. It serves consumers, patients, growers, manufacturers, and distributors. CannLabs, Inc. is based in Denver, Colorado. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.02 Daily Weekly Monthly 20 Day Moving Average: 20,230 shares Shares Outstanding: 813.16 (millions) Market Capitalization: $13.42 (millions) Beta: 1.85 52 Week High: $0.13 52 Week Low: $0.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -34.00% -24.99% 12 Week -18.32% -12.03% Year To Date -50.60% -39.99%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3888 E. MEXICO AVENUE - DENVER,CO 80210 USA ph: 303-309-0105 fax: - investors@cannlabs.com http://www.cannlabs.com

• General Corporate Information    Officers Mark Rogers - Chairman of the Board Mark C. Mirken - Chief Executive Officer and Director Genifer Murray - Founder; President and Director Scott A. McPherson - ChiefFinancial Officer and Principal Accounting Of Kenneth Johnsen - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 13767T102 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 813.16 Most Recent Split Date: (:1) Beta: 1.85 Market Capitalization: $13.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Quick Ratio 03/31/22 - - 12/31/21 - - 09/30/21 - - Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - - 09/30/21 - - Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©